Skip to main content

Advertisement

Log in

Clinical outcomes associated with anticholinergic burden in older hospitalized patients with advanced cancer: a single-center database study

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Although anticholinergic burden has been known to be associated with adverse outcomes in older adults, its clinical importance has been less studied in patients with advanced cancer. We aimed to assess clinical impacts of using anticholinergic medications in older patients with cancer.

Methods

This is a single-center retrospective database study. This study included patients with stage IV solid cancer aged 65 years or older who were hospitalized in a hospitalist-operated medical unit of a tertiary hospital. We calculated anticholinergic cognitive burden (ACB) scores on admission and during hospitalization by reviewing all medications during hospital stays and collected the following data: demographic, medical history and clinical severity, occurrence of delirium, location of discharge, in-hospital mortality, and after discharge mortality data.

Results

When we divided the patients into two groups based on the change in ACB during hospitalization, the in-hospital mortality rate, incidence of delirium, frequency of transfers to long-term care hospitals, and length of hospital stay were higher in the ACB-increased group than those in the non-increased group. Even after excluding patients with clinically detected delirium, increased ACB were associated with increased in-hospital mortality. Patients in the ACB-increased group showed higher mortality risk after discharge than those in the non-increased group based on the Cox proportional hazard model.

Conclusion

Increased ACB during hospitalization is a predictor of worsening clinical features and higher mortality in older patients with cancer. Further studies investigating causal relationship between an increased ACB and poor prognosis are warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The data that support the findings of this study are available on request from the corresponding author, Han SJ. The data are not publicly available due to restrictions for the death data received from the Korea Statistics Promotion Institute, which could compromise the privacy of research participants.

References

  1. Pilleron S, Sarfati D, Janssen-Heijnen M, Vignat J, Ferlay J, Bray F, Soerjomataram I (2019) Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer 144:49–58

    Article  CAS  Google Scholar 

  2. Mohile SG, Dale W, Somerfield MR, Schonberg MA, Boyd CM, Burhenn PS, Canin B, Cohen HJ, Holmes HM, Hopkins JO, Janelsins MC, Khorana AA, Klepin HD, Lichtman SM, Mustian KM, Tew WP, Hurria A (2018) Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol 36:2326–2347

    Article  Google Scholar 

  3. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27:2758–2765

    Article  Google Scholar 

  4. Cohen HJ, Smith D, Sun CL, Tew W, Mohile SG, Owusu C, Klepin HD, Gross CP, Lichtman SM, Gajra A, Filo J, Katheria V, Hurria A, for the Cancer and Aging Research Group (2016) Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy. Cancer 122:3865–3872

    Article  Google Scholar 

  5. Flood KL, Carroll MB, Le CV, Ball L, Esker DA, Carr DB (2006) Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit. J Clin Oncol 24:2298–2303

    Article  Google Scholar 

  6. Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, Lichtman SM, Gajra A, Bhatia S, Katheria V, Klapper S, Hansen K, Ramani R, Lachs M, Wong FL, Tew WP (2011) Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol 29:3457–3465

    Article  CAS  Google Scholar 

  7. Sharma M, Loh KP, Nightingale G, Mohile SG, Holmes HM (2016) Polypharmacy and potentially inappropriate medication use in geriatric oncology. J Geriatr Oncol 7:346–353

    Article  CAS  Google Scholar 

  8. Gross CP, Guo Z, McAvay GJ, Allore HG, Young M, Tinetti ME (2006) Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc 54:1898–1904

    Article  Google Scholar 

  9. Bähler C, Huber CA, Brüngger B, Reich O (2015) Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study. BMC Health Serv Res 15:23

    Article  Google Scholar 

  10. Lees J, Chan A (2011) Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol 12:1249–1257

    Article  Google Scholar 

  11. Jung HW, Kim KI (2014) Multimorbidity in older adults. J Korean Geriatr Soc 18:65–71

    Article  Google Scholar 

  12. Kintzel PE, Chase SL, Thomas W, Vancamp DM, Clements EA (2009) Anticholinergic medications for managing noisy respirations in adult hospice patients. Am J Health Syst Pharm 66:458–464

    Article  Google Scholar 

  13. Gill SS, Mamdani M, Naglie G, Streiner DL, Bronskill SE, Kopp A, Shulman KI, Lee PE, Rochon PA (2005) A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med 165:808–813

    Article  Google Scholar 

  14. Lattanzio F, Onder G, La Fauci MM et al (2018) Anticholinergic burden is associated with increased mortality in older patients with dependency discharged from hospital. J Am Med Dir Assoc 19:942–947

    Article  Google Scholar 

  15. Zimmerman KM, Salow M, Skarf LM, Kostas T, Paquin A, Simone MJ, Rudolph J (2014) Increasing anticholinergic burden and delirium in palliative care inpatients. Palliat Med 28:335–341

    Article  Google Scholar 

  16. Lee JH, Jung H-W, Jang I-Y, do Moon S, Lee S, Han SJ (2020) Anticholinergic cognitive burden as a predictive factor for in-hospital mortality in older patients in Korea. Ann Geriatr Med Res 24:20–26

  17. Welsh TJ, van der Wardt V, Ojo G, Gordon AL, Gladman JR (2018) Anticholinergic drug burden tools/scales and adverse outcomes in different clinical settings: a systematic review of reviews. Drugs Aging 35:523–538

    Article  CAS  Google Scholar 

  18. Page RL, SA II, Bryant LL, Ruscin JM (2010) Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging 5:75

    Article  CAS  Google Scholar 

  19. Hukins D, Macleod U, Boland JW (2019) Identifying potentially inappropriate prescribing in older people with dementia: a systematic review. Eur J Clin Pharmacol 75:467–481

    Article  Google Scholar 

  20. Scott IA, Hilmer SN, Reeve E, Potter K, le Couteur D, Rigby D, Gnjidic D, del Mar CB, Roughead EE, Page A, Jansen J, Martin JH (2015) Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med 175:827–834

    Article  Google Scholar 

  21. Flood KL, Carroll MB, Le CV, Brown CJ (2009) Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit. Am J Geriatr Pharmacother 7:151–158

    Article  Google Scholar 

  22. Campbell N, Maidment I, Fox C, Khan B, Boustani M (2013) The 2012 update to the anticholinergic cognitive burden scale. J Am Geriatr Soc 61:S142–S143

    Google Scholar 

  23. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Clin Epidemiol 40:373–383

    CAS  Google Scholar 

  24. LeBlanc TW, McNeil MJ, Kamal AH, Currow DC, Abernethy AP (2015) Polypharmacy in patients with advanced cancer and the role of medication discontinuation. Lancet Oncol 16:e333–e341

    Article  Google Scholar 

  25. Hochman MJ, Kamal AH, Wolf SP et al (2016) Anticholinergic drug burden in noncancer versus cancer patients near the end of life. J Pain Symptom Manag 52:737–743.e733

    Article  Google Scholar 

  26. Gupte KP, Wu W (2015) Impact of anticholinergic load of medications on the length of stay of cancer patients in hospice care. Int J Pharm Pract 23:192–198

    Article  Google Scholar 

  27. Utech AE, Tadros EM, Hayes TG, Garcia JM (2012) Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers. J Cachexia Sarcopenia Muscle 3:245–251

    Article  Google Scholar 

  28. Kilgour RD, Vigano A, Trutschnigg B, Lucar E, Borod M, Morais JA (2013) Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients. Support Care Cancer 21:3261–3270

    Article  CAS  Google Scholar 

  29. Morita T, Tei Y, Tsunoda J, Inoue S, Chihara S (2001) Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients. J Pain Symptom Manag 22:997–1006

    Article  CAS  Google Scholar 

  30. De la Cruz M, Ransing V, Yennu S et al (2015) The frequency, characteristics, and outcomes among cancer patients with delirium admitted to an acute palliative care unit. Oncologist 20:1425–1431

    Article  Google Scholar 

  31. Pasina L, Colzani L, Cortesi L, Tettamanti M, Zambon A, Nobili A, Mazzone A, Mazzola P, Annoni G, Bellelli G (2019) Relation between delirium and anticholinergic drug burden in a cohort of hospitalized older patients: an observational study. Drugs Aging 36:85–91

    Article  CAS  Google Scholar 

  32. Ogawa A, Okumura Y, Fujisawa D, Takei H, Sasaki C, Hirai K, Kanno Y, Higa K, Ichida Y, Sekimoto A, Asanuma C (2019) Quality of care in hospitalized cancer patients before and after implementation of a systematic prevention program for delirium: the DELTA exploratory trial. Support Care Cancer 27:557–565

    Article  Google Scholar 

  33. Cesari M, Colloca G, Cerullo F, Ferrini A, Testa AC, Foti E, Ciaburri M, Scambia G, Bernabei R, Gambassi G (2011) Onco-geriatric approach for the management of older patients with cancer. J Am Med Dir Assoc 12:153–159

    Article  Google Scholar 

Download references

Funding

This study was supported by grant No.0420202070 from the Seoul National University Hospital Research Fund.

Author information

Authors and Affiliations

Authors

Contributions

All authors meet the criteria for authorship as stated in the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as well as because of their contributions to the manuscript. Conceptualization: Seung Jun Han; data curation: Jin Lim, Sung do Moon, Hyeanji Kim; formal analysis: Seung Jun Han, Jae Hyun Lee, Jin Lim; funding acquisition: Hee-Won Jung; Methodology: Seung Jun Han, Jae Hyun Lee; supervision: Hee-Won Jung; validation; Hongran Moon, Seo-Young Lee; visualization: Jae Hyun Lee, Hee-Won Jung; writing–original draft: Jae Hyun Lee, Jin Lim; writing–review and editing: Seung Jun Han, Hee-Won Jung.

Corresponding author

Correspondence to Seung Jun Han.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethics approval and consent to participate

This study was carried out in accordance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Seoul National University Hospital (Approval No. H-2006-025-1130). This study waived the need for informed consent because of the retrospective nature of the study.

Consent for publication

The submission does not include images that may identify the person.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, J.H., Lim, J., Han, S.J. et al. Clinical outcomes associated with anticholinergic burden in older hospitalized patients with advanced cancer: a single-center database study. Support Care Cancer 29, 4607–4614 (2021). https://doi.org/10.1007/s00520-021-06008-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-021-06008-z

Keywords

Navigation